SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20 | -80.8% | 35,051 | -56.2% | 0.00% | – |
| Q2 2023 | $104 | +395.2% | 80,078 | +536.1% | 0.00% | – |
| Q1 2023 | $21 | -72.0% | 12,589 | -48.0% | 0.00% | – |
| Q4 2022 | $75 | -99.9% | 24,210 | -10.2% | 0.00% | – |
| Q3 2022 | $131,000 | +18.0% | 26,964 | +0.2% | 0.00% | – |
| Q2 2022 | $111,000 | +58.6% | 26,919 | +121.2% | 0.00% | – |
| Q1 2022 | $70,000 | +7.7% | 12,168 | +37.9% | 0.00% | – |
| Q4 2021 | $65,000 | 0.0% | 8,826 | +21.5% | 0.00% | – |
| Q3 2021 | $65,000 | -66.3% | 7,266 | -55.3% | 0.00% | – |
| Q2 2021 | $193,000 | +9550.0% | 16,256 | +7092.9% | 0.00% | – |
| Q1 2021 | $2,000 | -97.6% | 226 | -95.8% | 0.00% | – |
| Q4 2020 | $83,000 | – | 5,347 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |